Category: Dr. Edgerly, Executive Director
About 100 Alzheimer’s Scientists gathered Monday at the Alzheimer’s Association Researchers Symposium. This annual event is organized by the volunteer Medical and Scientific Advisory Council of the Alzheimer’s Association, Northern California and Northern Nevada...
The Alzheimer’s Association had the pleasure of presenting a new investigator research check to Masashi Kitazawa, Ph.D. at the University of California, Merced. Alzheimer’s Association New Investigator grans fund the next generation of...
There has been news coverage of the start of a clinical trial sponsored by a company called Functional Neuromodulation of deep brain stimulation (DBS) for mild Alzheimer’s disease. The study is being conducted in...
Two articles released by the New England Journal of Medicine (NEJM) report on a newly identified risk gene for Alzheimer’s disease. Background Genetic mutations that are confirmed as Alzheimer’s risk genes tell us more...
I’m pleased to share with you that the Alzheimer’s Association presented a research grant check to Gil Rabinovici, M.D., neurologist at the University of California at San Francisco. Dr. Rabinovichi has received support from...
Eli Lilly and Co. (Lilly) recently released additional data from two Phase 3 clinical trials of solanezumab for mild to moderate Alzheimer’s disease. In addition, scientists at the Alzheimer’s Disease Cooperative Study (ADCS) reported...
I’m a big fan of microwave popcorn so I was disheartened to see dozens of headlines in the past couple weeks that imply the butter flavoring in popcorn could be related to Alzheimer’s. I...
With the Alzheimer’s Association International Conference winding down, I thought it would be a great point to reflect on some of the unsung heroes who are critical in making this research happen: participants in...